Polyneuropathies inflammatoires démyélinisantes chroniques : problème thérapeutique au long cours

[1]  R. Hughes,et al.  Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. , 2017, The Cochrane database of systematic reviews.

[2]  R. D. de Haan,et al.  Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. , 2013, The Cochrane database of systematic reviews.

[3]  R. Weinstein,et al.  Rituximab treatment in patients with IVIg‐dependent immune polyneuropathy: A prospective pilot trial , 2007, Muscle & nerve.

[4]  R. Sakakibara,et al.  Remission of chronic inflammatory demyelinating polyneuropathy after alemtuzumab (Campath 1H) , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[5]  T. Kuntzer.  Les limites thérapeutiques des polyradiculonévrites chroniques , 2006 .

[6]  J. Pollard,et al.  European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society , 2006, European journal of neurology.

[7]  R. Hughes,et al.  Treatment of chronic inflammatory demyelinating polyradiculoneuropathy with methotrexate , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[8]  T. Brannagan,et al.  Diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy , 2006, Current treatment options in neurology.

[9]  M. Kubota,et al.  Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[10]  D. D. Bodley-Scott.  Chronic Inflammatory Demyelinating Polyradiculoneuropathy Responding to Rituximab , 2005, Practical Neurology.

[11]  K. Hirata,et al.  Intractable chronic inflammatory demyelinating polyneuropathy treated successfully with ciclosporin , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[12]  C. Vedeler,et al.  Onset and course of chronic inflammatory demyelinating polyneuropathy , 2005, Muscle & nerve.

[13]  J. Léger.  A review of the medical management of chronic inflammatory demyelinating polyradiculoneuropathy , 2005, Expert opinion on pharmacotherapy.

[14]  G. Mancardi,et al.  Mycophenolate mofetil in dysimmune neuropathies: A preliminary study , 2004, Muscle & nerve.

[15]  A. Hays,et al.  Etanercept (Enbrel®) therapy for chronic inflammatory demyelinating polyneuropathy , 2003, Journal of the Neurological Sciences.

[16]  P. Preux,et al.  Interferon beta-1a as an investigational treatment for CIDP , 2003, Neurology.

[17]  R. Hughes,et al.  Mycophenolate in treatment‐resistant inflammatory neuropathies , 2002, European journal of neurology.

[18]  M. Mori,et al.  Distribution patterns of demyelination correlate with clinical profiles in chronic inflammatory demyelinating polyneuropathy , 2002, Journal of neurology, neurosurgery, and psychiatry.

[19]  W. Bradley,et al.  Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory polyneuropathy and inclusion body myositis , 2001, Journal of the Neurological Sciences.

[20]  G. Sobue,et al.  Age of onset influences clinical features of chronic inflammatory demyelinating polyneuropathy , 2001, Journal of the Neurological Sciences.

[21]  D. Pareyson,et al.  Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients , 2000, Neurological Sciences.

[22]  B. Sharrack,et al.  Randomized trial of interferon β-1a in chronic inflammatory demyelinating polyradiculoneuropathy , 1999, Neurology.

[23]  F. Chédru,et al.  Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy , 1999, Neurology.

[24]  R. F. Mayer,et al.  Pulse cyclophosphamide therapy in chronic inflammatory demyelinating polyneuropathy , 1998, Neurology.

[25]  A. Ropper,et al.  Treatment of chronic inflammatory demyelinating polyneuropathy with interferon-α 2a , 1998, Neurology.

[26]  A. Ropper,et al.  Chronic inflammatory demyelinating polyneuropathy , 1997, Neurology.

[27]  M. Vérin,et al.  Chronic dysimmune demyelinating polyneuropathy: a clinical and electrophysiological study of 93 patients. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[28]  J. Mendell,et al.  Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. , 1989, Archives of neurology.

[29]  J. Mcleod,et al.  Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases. , 1987, Brain : a journal of neurology.

[30]  J. Daube,et al.  Combined azathioprine and prednisone in chronic inflammatory‐demyelinating polyneuropathy , 1985, Neurology.

[31]  R. Dinapoli,et al.  Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment , 1982, Annals of neurology.

[32]  R. Hughes,et al.  Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy. , 2004, The Cochrane database of systematic reviews.